ZOMDF · Zomedica Corp. · Executive Compensation
$0.09
+0.00 (+1.39%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q1 2026 earnings call transcript
Market Cap
$92.41M
Shares
979.95M
Volume · Nov 6
1.14M
Avg daily vol (3M)
880.55K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Scott Jordan | Chief Financial Officer | Resigned | 2025-04-30 |
| Scott Jordan | Chief Financial Officer | Appointed | 2024-12-19 |
| Peter Donato | Executive Vice President and Chief Financial Officer | Resigned | 2024-08-14 |
| Peter Donato | Chief Financial Officer | Appointed | 2023-03-17 |
| Ann Marie Cotter | Chief Financial Officer | Resigned | 2023-03-17 |
| Dr. Pamela Nichols | Director | Appointed | 2022-08-24 |
Leadership
- Larry Heaton CEO, Board Member
- Robert Cohen CEO, Board Member
- Jeffrey Rowe Chairman
- Ann Cotter CFO
- Peter Donato CFO
- Scott Jordan CFO
- Anthony K. Blair COO
- Karen DeHaan-Fullerton General Counsel
- Chris MacLeod Board Member
- Christopher R. MacLeod Board Member
- Christopher Wolfenberg Board Member
- Dr. Pamela Nichols Board Member
- Johnny D. Powers Board Member
- Pam Nichols Board Member
- Rodney Williams Board Member
- Sean Whelan Board Member
Key facts
CIK
1684144
CUSIP
98980M109
13F (30d)
20 filings
5 filers
Visit website
Investor relations